Clinical Trial: A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670884) titled 'A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects' on June 22.

Brief Summary: This study aims to evaluate the efficacy and safety of HRS9531 tablets compared with placebo in reducing body weight in overweight or obese subjects after 52 weeks of treatment.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Chronic Management of Body Weight

Intervention: DRUG: HRS9531 Tablet

HRS9531 tablet.

DRUG: HRS9531 Tablet Placebo

HRS9531 tablet placebo.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

Published by HT Digital C...